drugset / Trial / NCT00538811
Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders
RandomizedParallel-groupOpen-labelTreatment
Summary
When administered simultaneously, interferon-alpha 2b + interferon-gamma result in dramatic antiviral synergy.Ribavirin has shown to enhance interferon-gamma levels in patients with chronic hepatitis C treated with interferon-alpha. Enhancement of immune responses, especially those related to type-1 T helper cell activity, may contribute to better efficacy in combining ribavirin with IFN-alpha for treatment of chronic hepatitis C. The aim of the present study is to evaluate the efficacy and safety of a triple regimen, a combination treatment with Interferon gamma, Interferon alfa-2b plus Ribavirin in patients who have not previously responded to interferon alpha in combination of ribavirin.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amantadine | Unknown | 100 mg | — |
| Subject | interferon gamma | Protein / enzyme biologic | 2 iu | — |
| Background | Ribavirin | Small molecule | 800 mg | — |
| Background | Ribavirin | Small molecule | 1200 mg | — |
| Background | interferon alfa-2b | Protein / enzyme biologic | 3 iu | — |